Aberdeen US Small Cap Equity C (GSXCX)

27.45 +0.33  +1.22% Jan 16 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 27.45
Turnover Ratio 38.28%
1 Year Fund Level Flows -689.72M

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 4.52% 4.57% 75
3M 9.63% 11.56% 87
6M 11.34% 6.39% 11
YTD 3.66% 2.52% 53
1Y 19.86% 22.68% 67
3Y 6.87% 13.76% 93
5Y 10.25% 11.42% 69
10Y 12.18% 12.79% 71
15Y 9.00% 9.33% 68
20Y 8.72% 7.51% --
As of Jan. 16, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 2.13% 2.13% 0.00%
Stock 97.87% 97.87% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Dec. 31, 2019

Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00%
Greater Europe 0.00%
United Kingdom 0.00%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Nov. 30, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 8.69%
Communication Services 0.00%
Consumer Cyclical 9.26%
Consumer Defensive 8.23%
Energy 0.78%
Financial Services 11.94%
Healthcare 15.36%
Industrials 19.83%
Real Estate 1.57%
Technology 23.03%
Utilities 1.32%
As of Dec. 31, 2019

Stock Market Capitalization

Giant 0.00%
Large 0.00%
Medium 20.42%
Small 75.20%
Micro 4.38%
As of Dec. 31, 2019

Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 0.00%
Large Cap Growth 0.00%
Mid Cap Value 0.00%
Mid Cap Blend 9.89%
Mid Cap Growth 10.61%
Small Cap Value 14.49%
Small Cap Blend 18.69%
Small Cap Growth 46.32%
As of Dec. 31, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
GMED Globus Medical Inc Class A 3.28% 53.30 +0.02%
NP Neenah Inc 2.88% 67.61 +0.33%
HZNP Horizon Therapeutics PLC 2.61% 38.50 +0.55%
LCII LCI Industries Inc 2.58% 110.96 -0.21%
FIVN Five9 Inc 2.54% 73.20 -0.15%
BJ BJ's Wholesale Club Holdings Inc 2.49% 22.75 +0.09%
CWST Casella Waste Systems Inc Class A 2.48% 49.54 -2.04%
NSIT Insight Enterprises Inc 2.41% 70.54 -1.20%
HELE Helen Of Troy Ltd 2.17% 183.34 -1.07%
KWR Quaker Chemical Corp 2.15% 168.86 -0.44%
As of Dec. 31, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks long-term capital appreciation. The fund normally invests at least 80% of the value of its net assets, plus any borrowings for investment purposes, in equity securities issued by U.S. small-cap companies. The advisor considers small-cap companies to be companies that have market capitalizations similar to those of companies included in the Russell 2000® Index at the time of investment. It also may invest in foreign securities and securities of larger companies.
General
Security Type Mutual Fund
Oldest Share Symbol GSXIX
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Small Growth
Prospectus Objective Small Company
Fund Owner Firm Name Aberdeen
Benchmark Index
Russell 2000 TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Francis Radano 2.75 yrs
Jason Kotik 11.10 yrs
Ralph Bassett 11.10 yrs
Tim Skiendzielewski 0.36 yrs

Share Classes

Symbol Share Class
GNSRX Retirement
GSCIX Inst
GSXAX A
GSXIX Inst

Net Fund Flows

1M -10.97M
3M -61.05M
6M -360.61M
YTD -689.72M
1Y -689.72M
3Y -1.029B
5Y 298.91M
10Y 34.82M
As of Dec. 31, 2019

Risk Info

Beta (5Y) 1.030
Historical Sharpe Ratio (10Y) 0.7865
Historical Sortino (All) 0.5351
Daily Value at Risk (VaR) 1% (All) 3.65%
Monthly Value at Risk (VaR) 1% (All) 17.66%

Fundamentals

Dividend Yield TTM (1-16-20) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 25.71
Weighted Average Price to Sales Ratio 1.528
Weighted Average Price to Book Ratio 2.937
Weighted Median ROE 11.42%
Weighted Median ROA 5.29%
Forecasted Dividend Yield 0.83%
Forecasted PE Ratio 21.98
Forecasted Price to Sales Ratio 1.590
Forecasted Price to Book Ratio 2.981
Number of Holdings 56
As of Nov. 30, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 11.57%
Forecasted Book Value Growth 9.86%
Forecasted Cash Flow Growth 5.02%
Forecasted Earnings Growth 11.55%
Forecasted Revenue Growth 10.57%
As of Nov. 30, 2019

Comparables

Edit

Attributes

Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment 1000.00 USD
Minimum Subsequent Investment 50.00 USD
Fees
Actual 12B-1 Fee 1.00%
Actual Management Fee 0.81%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load 1.00%
Maximum Redemption Fee --
Key Dates
Inception Date 3/1/2001
Termination Date
Last Annual Report Date 10/31/2018
Last Prospectus Date 2/28/2019
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.